Verified Service Provider in Mozambique
Molecular Diagnostics Labs in Mozambique
Engineering Excellence & Technical Support
Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
Next-Generation Sequencing (NGS) for Pathogen Surveillance
Leveraging cutting-edge Next-Generation Sequencing (NGS) technology to rapidly identify and track infectious disease outbreaks. Our capabilities enable real-time genomic surveillance for emerging threats, informing public health interventions and policy decisions across Mozambique.
High-Throughput PCR for Disease Screening
Implementing high-throughput Polymerase Chain Reaction (PCR) platforms for efficient and accurate diagnosis of a wide range of infectious diseases. This allows for faster patient results, improved resource allocation, and enhanced capacity for mass screening programs.
Integrated Data Management & Bioinformatics
Our advanced laboratory infrastructure includes robust data management systems and in-house bioinformatics expertise. This ensures seamless integration of molecular diagnostic results with clinical data, facilitating advanced analysis, research, and evidence-based healthcare delivery in Mozambique.
What Is Molecular Diagnostics Labs In Mozambique?
Molecular Diagnostics Laboratories (MDLs) in Mozambique are specialized healthcare facilities equipped with advanced instrumentation and trained personnel to perform complex biological tests. These tests analyze genetic material (DNA and RNA) or specific proteins to identify infectious agents, detect genetic mutations associated with diseases, and assess an individual's predisposition to certain conditions. The core of molecular diagnostics lies in the amplification and detection of specific nucleic acid sequences or the quantification of protein biomarkers, enabling highly sensitive and specific diagnostic outcomes that are often unattainable through traditional methods.
| Who Needs Molecular Diagnostics? | Typical Use Cases in Mozambique | ||||
|---|---|---|---|---|---|
| Individuals with Suspected Infectious Diseases: Patients presenting with symptoms suggestive of bacterial, viral, fungal, or parasitic infections, especially when conventional tests are inconclusive or delayed. | Diagnosis of HIV/AIDS: Early infant diagnosis (EID) of HIV through PCR, viral load monitoring, and genotypic drug resistance testing to guide antiretroviral therapy (ART). | Tuberculosis (TB) Diagnosis: Detection of Mycobacterium tuberculosis complex and identification of drug-resistant strains (e.g., rifampicin resistance using Xpert MTB/RIF). | Malaria Diagnosis: Identification of Plasmodium species, particularly in cases of suspected severe malaria or when microscopy is unavailable or unreliable. | ||
| Individuals at Risk for Genetic Disorders: Patients with a family history of inherited diseases or those requiring carrier screening. | Hepatitis B and C Diagnosis and Management: Quantification of viral load for treatment monitoring and genotypic resistance testing. | Emerging Infectious Diseases: Rapid identification and characterization of novel pathogens during outbreaks (e.g., SARS-CoV-2 for COVID-19 diagnosis, including variant tracking). | Oncology Patients: Identification of specific genetic mutations in tumors to guide targeted therapies and prognosis assessment (though this is less widespread in resource-limited settings like Mozambique). | Public Health Surveillance Programs: Monitoring the prevalence of specific pathogens, tracking drug resistance patterns, and supporting national disease control strategies. | Blood Banks and Transfusion Services: Screening of donated blood for infectious agents to ensure transfusion safety. |
Key Aspects of Molecular Diagnostics Laboratories in Mozambique:
- Technological Foundation: MDLs utilize technologies such as Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), DNA sequencing (including next-generation sequencing - NGS), and various immunoassay platforms.
- Specimen Types: A wide range of biological specimens can be analyzed, including blood, urine, saliva, sputum, cerebrospinal fluid, tissue biopsies, and swabs.
- Diagnostic Precision: Offers high sensitivity and specificity, allowing for the detection of even minute quantities of target molecules, leading to earlier and more accurate diagnoses.
- Therapeutic Guidance: Provides information crucial for guiding treatment decisions, including selecting appropriate antimicrobial agents, identifying drug resistance, and personalizing therapeutic regimens.
- Disease Surveillance: Plays a critical role in public health by enabling the rapid identification and tracking of infectious disease outbreaks, facilitating timely public health interventions.
- Research and Development: Supports ongoing research efforts in understanding disease pathogenesis, identifying novel biomarkers, and developing new diagnostic and therapeutic strategies.
Who Needs Molecular Diagnostics Labs In Mozambique?
Molecular diagnostics labs are crucial for advancing healthcare in Mozambique, offering precise and rapid identification of diseases, guiding treatment decisions, and supporting public health initiatives. Their services are indispensable for a range of stakeholders, from individual patients to national health programs.
| Department/Customer Type | Key Needs Addressed by Molecular Diagnostics | Specific Examples/Applications |
|---|---|---|
| Infectious Disease Wards/Departments | Rapid and accurate diagnosis of bacterial, viral, and parasitic infections; antimicrobial resistance (AMR) testing; differentiating similar presenting symptoms. | Tuberculosis (TB) testing (e.g., GeneXpert), HIV viral load and resistance testing, malaria diagnosis, identification of sepsis pathogens, COVID-19 testing, identification of neglected tropical diseases (NTDs). |
| Oncology Departments | Identification of cancer types and subtypes; predictive and prognostic biomarkers; monitoring treatment response; personalized medicine. | Detection of specific gene mutations for targeted cancer therapies (e.g., EGFR in lung cancer, BRAF in melanoma), HPV testing for cervical cancer screening. |
| Maternal and Child Health (MCH) Services | Screening for congenital infections; diagnosis of childhood illnesses; genetic screening. | Congenital CMV testing, diagnosis of diarrheal diseases in children, rapid identification of respiratory infections. |
| Public Health Laboratories/National Reference Labs | Disease surveillance and outbreak detection; epidemiological studies; quality control of diagnostics; reference testing. | Genomic sequencing for outbreak tracing (e.g., tracking emergence and spread of infectious agents), confirmation of rare or complex diagnoses, drug resistance surveillance. |
| Research Institutions and Universities | Fundamental research into disease mechanisms; development of new diagnostic tools; clinical trials. | Investigating the genetic basis of diseases prevalent in Mozambique; validating novel molecular assays. |
| Blood Banks | Screening of blood donations for infectious agents to ensure transfusion safety. | Nucleic acid testing (NAT) for HIV, Hepatitis B and C, and West Nile Virus. |
| Government Health Agencies (Ministry of Health, National AIDS Control Program, etc.) | Informing public health policy; resource allocation; monitoring disease burden and program effectiveness; guiding national health strategies. | Data on prevalence of drug-resistant TB for policy decisions; tracking HIV transmission dynamics; informing vaccine rollout strategies. |
| NGOs and International Health Organizations | Implementing targeted health programs; diagnostics for remote or underserved populations; rapid response to epidemics. | Deploying mobile labs for outbreak investigations; providing diagnostics for HIV/AIDS, TB, and malaria programs; supporting maternal health initiatives with STI screening. |
| Veterinary Services/Public Health Interface | Surveillance of zoonotic diseases; identification of animal pathogens with public health implications. | Testing for diseases like Rift Valley Fever, Avian Influenza, or rabies in animal populations to prevent human transmission. |
Target Customers and Departments
- Hospitals (Public and Private)
- Clinics and Health Centers
- Research Institutions
- Government Health Agencies
- Non-Governmental Organizations (NGOs) involved in health
- Blood Banks
- Veterinary Services (for zoonotic disease surveillance)
Molecular Diagnostics Labs Process In Mozambique
The workflow of Molecular Diagnostics Laboratories in Mozambique, from initial inquiry to the final execution of diagnostic tests, involves a structured process to ensure accurate and timely results. This process is crucial for disease surveillance, patient management, and public health interventions. The steps are generally standardized but may have slight variations depending on the specific laboratory, the type of test being performed, and the available resources within Mozambique's healthcare system.
| Stage | Description | Key Activities | Actors Involved | Considerations in Mozambique |
|---|---|---|---|---|
| Inquiry & Request Generation | The process begins when a healthcare provider or public health official identifies a need for molecular diagnostic testing. | Clinical assessment, identification of suspected condition, filling out laboratory request forms, specifying the test required (e.g., for HIV viral load, TB, COVID-19, malaria). | Clinicians, Public Health Officers, Patients (indirectly). | Ensuring availability of standardized request forms, clear communication channels between clinical sites and labs, potential for paper-based systems and need for digitization. |
| Sample Collection & Transportation | Appropriate biological samples are collected from the patient and transported to the laboratory under conditions that maintain sample integrity. | Collection of blood, sputum, swabs, urine, or other relevant specimens using appropriate collection kits and protocols. Proper labeling of samples with patient identifiers. Packaging samples for safe transport, often using biohazard bags and temperature-controlled containers. | Nurses, Laboratory Technicians, Phlebotomists, Couriers, Healthcare Facility Staff. | Challenges in transportation due to vast distances, poor road infrastructure, limited cold chain capabilities, ensuring trained personnel for collection and packaging, potential for sample degradation. |
| Sample Reception & Registration | Upon arrival at the laboratory, samples are formally received, logged, and assigned a unique laboratory identification number. | Visual inspection of sample integrity and labeling. Verification of request form against sample. Registration into Laboratory Information Management System (LIMS) or logbook. Allocation of unique laboratory IDs. Storage of samples in designated areas. | Laboratory Reception Staff, Laboratory Technicians, LIMS Administrator. | Importance of robust LIMS for tracking and reducing errors. Manual logging can be prone to errors. Need for secure sample storage, especially for time-sensitive tests. |
| Sample Preparation | The collected sample is processed to isolate the target nucleic acid (DNA or RNA). | Centrifugation, lysis of cells, removal of inhibitors. This stage is highly dependent on the type of sample and the specific assay. | Laboratory Technicians, Molecular Biologists. | Availability and cost of reagents, equipment (e.g., centrifuges, biosafety cabinets), and trained personnel are critical. Standard operating procedures (SOPs) must be followed meticulously. |
| Nucleic Acid Extraction | The critical step of isolating pure nucleic acids from the prepared sample. | Using commercial kits or manual methods to extract DNA or RNA. This often involves a combination of chemical treatments and physical separation techniques. | Laboratory Technicians, Molecular Biologists. | Reliability and affordability of extraction kits are vital. Contamination during extraction is a major concern, requiring strict adherence to sterile techniques and use of Biosafety Level 2 (BSL-2) facilities. |
| Amplification & Detection | The extracted nucleic acid is amplified to detect the presence of specific genetic material of the pathogen or disease marker. | Polymerase Chain Reaction (PCR), real-time PCR (RT-PCR), or other molecular amplification techniques. This involves using specific primers and enzymes to amplify target sequences. | Molecular Biologists, Laboratory Technicians. | Access to reliable PCR machines (thermocyclers), reagents, and consumables. Ensuring accurate calibration and maintenance of equipment. Training on various molecular techniques. |
| Data Analysis & Interpretation | The raw data generated by the amplification and detection step is analyzed and interpreted to determine the test result. | Reading and analyzing amplification curves (for RT-PCR), gel electrophoresis results (for conventional PCR), or other output from the detection instrument. Comparing results to control samples (positive and negative controls). | Molecular Biologists, Laboratory Technicians, Pathologists (sometimes). | Requirement for trained personnel capable of interpreting complex data. Software for data analysis needs to be functional and accessible. Understanding of potential pitfalls and limitations of the assay. |
| Result Reporting | The final test result is communicated to the requesting healthcare provider or public health authority. | Generating a formal laboratory report (electronic or paper) indicating positive, negative, or inconclusive results. Including relevant details like test methodology, sample ID, and date. Sending reports through secure channels. | Laboratory Management, Laboratory Technicians, Administrative Staff. | Timeliness of reporting is paramount for patient management. Secure and confidential reporting mechanisms are essential. Need for standardized report formats that are easily understood by clinicians. |
| Quality Assurance & Control | Continuous monitoring and evaluation of all laboratory processes to ensure accuracy and reliability of results. | Running internal quality controls (positive and negative controls) with each batch of tests. Participating in external Quality Assurance (QA) or Proficiency Testing (PT) programs. Regular calibration and maintenance of equipment. Staff training and competency assessments. | Quality Assurance Officer, Laboratory Management, All Laboratory Staff. | Crucial for building trust in diagnostic results. Funding and access to QA/PT schemes can be challenging. Need for standardized QA protocols across the country. |
| Waste Management & Decontamination | Safe disposal of biological waste and decontamination of laboratory surfaces and equipment. | Segregation of biohazardous waste, proper autoclaving or incineration of waste, disinfection of work areas and equipment, adherence to biosafety protocols. | All Laboratory Staff, Environmental Health Officers (sometimes). | Proper waste disposal infrastructure and trained personnel are vital for preventing the spread of infections and protecting the environment. Access to disinfectants and autoclaves. |
Molecular Diagnostics Lab Process in Mozambique: From Inquiry to Execution
- Inquiry & Request Generation
- Sample Collection & Transportation
- Sample Reception & Registration
- Sample Preparation
- Nucleic Acid Extraction
- Amplification & Detection
- Data Analysis & Interpretation
- Result Reporting
- Quality Assurance & Control
- Waste Management & Decontamination
Molecular Diagnostics Labs Cost In Mozambique
Molecular diagnostics labs in Mozambique play a crucial role in disease detection and management. The cost of these diagnostic services is influenced by several factors, leading to a range of prices for various tests. Understanding these pricing dynamics is essential for patients, healthcare providers, and policymakers. The cost is primarily driven by the complexity of the test, the technology and reagents used, the overhead of the laboratory, and the specific disease or condition being investigated. For instance, tests requiring advanced equipment like PCR machines and specialized, often imported, reagents will inherently be more expensive than simpler antigen-based rapid tests. Laboratories operating in more urban centers with higher operating costs may also charge more than those in remote areas. Furthermore, government-subsidized testing for specific public health programs can significantly reduce costs for eligible individuals. The availability and accessibility of these tests can also vary, impacting the competitive landscape and pricing. It's important to note that pricing can fluctuate based on foreign exchange rates for imported materials and the overall economic climate in Mozambique.
| Type of Molecular Diagnostic Test | Estimated Price Range (MZN) | Notes |
|---|---|---|
| COVID-19 PCR Test | 1,500 - 4,000 | Varies by lab, speed of result, and whether it's a government-subsidized program. |
| HIV Viral Load Test | 2,000 - 5,000 | Crucial for treatment monitoring, costs can be subsidized for public health initiatives. |
| Hepatitis B/C PCR Test | 2,500 - 6,000 | For diagnosis and monitoring of viral hepatitis. |
| Tuberculosis (TB) PCR Test (e.g., GeneXpert) | 1,800 - 4,500 | Faster and more sensitive than traditional methods; often part of national TB programs. |
| Malaria PCR Test | 1,000 - 3,000 | More sensitive for low parasitemia compared to microscopy. |
| Genotyping Tests (e.g., for drug resistance) | 5,000 - 15,000+ | Complex tests, often performed at specialized reference labs. |
| Rapid Antigen Tests (e.g., COVID-19) | 300 - 800 | Less sensitive than PCR but faster and cheaper. |
Factors Influencing Molecular Diagnostics Lab Costs in Mozambique
- Test Complexity and Technology (e.g., PCR, sequencing vs. rapid antigen tests)
- Cost of Reagents and Consumables (often imported)
- Laboratory Overhead (staffing, rent, utilities, equipment maintenance)
- Specific Disease or Condition (some tests are inherently more resource-intensive)
- Geographic Location (urban vs. rural labs)
- Government Subsidies and Public Health Programs
- Import Duties and Value Added Tax (VAT) on imported materials
- Foreign Exchange Rates (affecting the cost of imported components)
- Laboratory Accreditation and Quality Standards
- Volume of Tests Performed (economies of scale)
Affordable Molecular Diagnostics Labs Options
Affordable molecular diagnostics labs are crucial for widespread access to essential health information. These facilities leverage advanced technology to detect and analyze genetic material, providing insights into diseases, infections, and individual predispositions. Several factors contribute to their affordability, including streamlined processes, optimized reagent utilization, and strategic partnerships. Understanding value bundles and implementing cost-saving strategies are key to making these vital services accessible to a broader population.
| Value Bundle Example | Included Tests | Potential Savings | Target Audience |
|---|---|---|---|
| Comprehensive Infectious Disease Panel | COVID-19, Influenza A/B, RSV, Strep A | 15-20% compared to individual tests | Primary care clinics, urgent care centers |
| Oncology Genetic Marker Panel | BRCA1/BRCA2, KRAS, EGFR mutations | 10-15% compared to separate genetic tests | Oncology centers, specialized clinics |
| Prenatal Genetic Screening Bundle | NIPT (Non-Invasive Prenatal Testing) + Carrier Screening | 10-12% compared to purchasing separately | Obstetrics and gynecology practices |
| Therapeutic Drug Monitoring Package | Selected drugs with established therapeutic ranges | 5-10% for multiple tests | Hospitals, psychiatric facilities |
| Basic Genetic Health Assessment | Predisposition to common conditions (e.g., Type 2 Diabetes, Heart Disease) | 20-25% compared to individual risk assessments | Wellness programs, direct-to-consumer markets |
Key Strategies for Affordable Molecular Diagnostics
- Value Bundles: Offering packaged diagnostic tests at a reduced combined price.
- Cost-Saving Strategies: Implementing measures to minimize expenses without compromising quality.
- Technology Optimization: Utilizing efficient and automated platforms to reduce manual labor and error rates.
- Reagent Management: Bulk purchasing, inventory control, and exploring alternative reagent suppliers.
- Partnerships and Collaborations: Sharing resources, equipment, and expertise with other institutions.
- Outreach Programs: Engaging with underserved communities to offer subsidized testing.
- Standardization of Protocols: Ensuring consistent and efficient workflows to reduce waste and retesting.
- Skilled Workforce Development: Investing in training to improve efficiency and reduce errors.
- Data Analytics for Efficiency: Using data to identify bottlenecks and areas for cost reduction.
- Focus on High-Volume Tests: Prioritizing common diagnostic tests to leverage economies of scale.
Verified Providers In Mozambique
Ensuring access to quality healthcare is paramount, and in Mozambique, identifying verified healthcare providers is crucial for individuals and families. This guide focuses on Franance Health and illuminates why their credentials position them as an optimal choice for your healthcare needs.
| Credential/Aspect | Franance Health's Verification/Attainment | Benefit to Patients |
|---|---|---|
| Medical Licenses & Certifications | All practitioners hold valid Mozambican medical licenses and relevant specialist certifications. | Ensures competence and adherence to professional standards. |
| Facility Accreditation | Franance Health facilities are accredited by recognized Mozambican health authorities and may hold international accreditations. | Guarantees a safe, clean, and well-equipped environment for treatment. |
| Quality Management Systems | Implementation of internationally recognized Quality Management Systems (e.g., ISO standards) where applicable. | Promotes continuous improvement in service delivery and patient safety. |
| Professional Development | Ongoing training and professional development programs for all staff. | Keeps medical teams updated on the latest advancements in medical science and practice. |
| Patient Feedback Mechanisms | Established channels for patient feedback and complaints, with a commitment to addressing concerns. | Empowers patients and drives service improvements based on user experience. |
| Partnerships with Reputable Insurers | Collaboration with leading health insurance providers in Mozambique. | Facilitates easier access to services and potentially covers a significant portion of healthcare costs. |
Why Franance Health Stands Out:
- Unwavering Commitment to Quality: Franance Health prioritizes high standards in all aspects of their service delivery, from patient care to administrative processes.
- Highly Qualified Medical Professionals: Their network comprises experienced and certified doctors, nurses, and specialists with diverse areas of expertise.
- Robust Accreditation and Certifications: Franance Health adheres to rigorous national and international healthcare standards, ensuring their facilities and practices are up to par.
- Patient-Centric Approach: A strong emphasis is placed on patient well-being, comfort, and clear communication throughout the healthcare journey.
- Accessibility and Affordability: Franance Health strives to make quality healthcare accessible, offering competitive pricing and a range of service options.
- Technological Integration: Embracing modern healthcare technologies to enhance diagnostic capabilities, treatment efficacy, and patient experience.
Scope Of Work For Molecular Diagnostics Labs
This document outlines the Scope of Work (SoW) for Molecular Diagnostics Laboratories, detailing the technical deliverables and standard specifications required for their establishment and operation. It covers various aspects from infrastructure and equipment to personnel and quality management, ensuring comprehensive and compliant molecular diagnostic services.
| Technical Deliverable | Standard Specification/Requirement | Description/Purpose |
|---|---|---|
| Laboratory Layout and Design Plan | ISO 15189, CAP, CLIA | Functional layout optimizing workflow, biosafety levels (BSL-2 or BSL-3), separation of pre-PCR, PCR, and post-PCR areas, adequate space for equipment, waste management, and staff. |
| Biosafety Cabinets (BSCs) | Class II or Class III (as per risk assessment) | Containment of biological agents, protection of personnel and samples during handling of infectious materials. |
| Real-Time PCR (qPCR) Systems | High throughput, multiplexing capability, spectral detection range | Amplification and detection of nucleic acid targets for diagnostic testing. |
| Automated Nucleic Acid Extraction Systems | High purity, high yield, compatibility with various sample types | Efficient and reproducible isolation of DNA/RNA from clinical specimens. |
| Centrifuges | Variable speed, refrigerated options | Sample processing, pelleting, and separation. |
| Incubators and Water Baths | Temperature control and stability | Assay incubation steps and reagent preparation. |
| Pipetting Systems (Manual and Automated) | Accuracy, precision, calibrated | Precise liquid handling for reagent addition and sample preparation. |
| Validated Molecular Assays | Sensitivity, specificity, accuracy, precision, LoD, LoQ | Established and verified kits or in-house developed assays for specific pathogens or genetic targets. |
| Quality Control Materials | Positive and negative controls, internal controls, external QC | Monitoring assay performance and ensuring accuracy of results. |
| Laboratory Information Management System (LIMS) | Data security, traceability, reporting features, integration capabilities | Management of patient data, sample tracking, test ordering, results reporting, and audit trails. |
| Standard Operating Procedures (SOPs) | Detailed, clear, version-controlled | Documented protocols for all laboratory procedures, equipment operation, maintenance, and safety. |
| Personnel Training Records | Documented training on SOPs, instrument operation, biosafety | Ensuring competency of all laboratory staff in their respective roles. |
| Proficiency Testing (PT) Participation Records | Regular participation in external PT schemes | External validation of laboratory performance against peer laboratories. |
| Instrument Calibration and Maintenance Logs | Regular, documented calibration and preventative maintenance | Ensuring the accuracy and reliability of laboratory equipment. |
| Waste Management Plan | Biohazard waste segregation, treatment, and disposal | Safe and compliant handling and disposal of biological and chemical waste. |
Key Areas of Scope of Work for Molecular Diagnostics Labs
- Laboratory Design and Infrastructure
- Equipment and Instrumentation
- Reagents, Consumables, and Supplies
- Personnel and Training
- Test Menu and Assay Development/Validation
- Quality Assurance and Quality Control (QA/QC)
- Data Management and Information Systems
- Safety and Biosafety
- Regulatory Compliance
- Operational Procedures and Workflow
Service Level Agreement For Molecular Diagnostics Labs
This Service Level Agreement (SLA) outlines the guaranteed response times and uptime for molecular diagnostics laboratory services. It defines the commitment of the laboratory to its clients regarding the speed of reporting results and the continuous availability of its diagnostic capabilities. This agreement is crucial for healthcare providers relying on timely and accurate molecular diagnostic data for patient care and treatment decisions.
| Service Component | Service Level Objective (SLO) | Measurement Method | Definition of Failure |
|---|---|---|---|
| Routine Molecular Diagnostic Tests (e.g., PCR for infectious agents) | 90% of results reported within 48 hours of sample receipt. | Timestamp of sample receipt vs. timestamp of final report issuance. | Failure to report 90% of routine tests within the 48-hour window over a monthly period. |
| High-Complexity Molecular Tests (e.g., Next-Generation Sequencing panels) | 90% of results reported within 7 business days of sample receipt. | Timestamp of sample receipt vs. timestamp of final report issuance. | Failure to report 90% of high-complexity tests within the 7-business-day window over a monthly period. |
| Critical Sample Reporting (e.g., positive identification of life-threatening pathogens) | Notification of critical results within 24 hours of preliminary result availability. | Timestamp of preliminary result availability vs. timestamp of verbal/electronic notification to client. | Failure to notify critical results within the 24-hour window on more than 2 occasions within a monthly period. |
| Diagnostic Platform Uptime | 99.5% uptime for core molecular diagnostic platforms (e.g., PCR machines, sequencers). | Monitoring of platform operational status and maintenance logs. | Any single platform downtime exceeding 4 hours within a month, or cumulative downtime exceeding 8 hours in a month. |
| Laboratory Information Management System (LIMS) Uptime | 99.9% uptime for LIMS, including result entry, retrieval, and reporting functions. | Monitoring of LIMS server availability and system responsiveness. | Any LIMS downtime exceeding 2 hours within a month, or cumulative downtime exceeding 4 hours in a month. |
Key Service Level Objectives
- Turnaround Time (TAT): The time elapsed from sample receipt by the laboratory to the issuance of a final, reportable result.
- Uptime Guarantee: The percentage of time the laboratory's diagnostic platforms and reporting systems are available and functional for receiving, processing, and reporting results.
- Critical Sample Prioritization: Procedures and timeframes for expedited processing and reporting of samples identified as critical.
- Communication Protocols: Methods and response times for communicating critical findings or issues affecting service delivery.
- Reporting and Escalation: Procedures for reporting SLA performance and escalating deviations.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Molecular Diagnostics Labs in Mozambique project in Mozambique.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.